Citius Oncology, Inc. CTOR Increase (Decrease) in Accounts Payable, Trade
Increase (Decrease) in Accounts Payable, Trade at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s increase (decrease) in accounts payable, trade.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s increase (decrease) in accounts payable, trade?
- Citius Oncology, Inc. (CTOR) reported increase (decrease) in accounts payable, trade of -$1.56M in Q1 2026.
- How has Citius Oncology, Inc.'s increase (decrease) in accounts payable, trade changed year-over-year?
- Citius Oncology, Inc.'s increase (decrease) in accounts payable, trade decreased by 186.8% year-over-year, from $1.8M to -$1.56M.
- What is the long-term trend for Citius Oncology, Inc.'s increase (decrease) in accounts payable, trade?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s increase (decrease) in accounts payable, trade has grown at a 182.1% compound annual growth rate (CAGR), from $1.2M to $9.52M.
- What does increase (decrease) in accounts payable, trade mean?
- Measures the net change in obligations owed to suppliers for goods and services received on credit. An increase suggests the company is conserving cash by extending payment terms, whereas a decrease indicates the settlement of outstanding trade liabilities.